• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎的发病机制:2022年回顾

Pathogenesis of rheumatoid arthritis: one year in review 2022.

作者信息

Petrelli Fiorella, Mariani Francesco Maria, Alunno Alessia, Puxeddu Ilaria

机构信息

Immuno-Allergology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Internal Medicine and Nephrology Unit, Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy.

出版信息

Clin Exp Rheumatol. 2022 Mar;40(3):475-482. doi: 10.55563/clinexprheumatol/l9lyen. Epub 2022 Mar 10.

DOI:10.55563/clinexprheumatol/l9lyen
PMID:35333708
Abstract

The mechanisms underlying the pathogenesis of rheumatoid arthritis (RA) involve different components of the immune system. In subjects with genetic predisposition to develop RA, a tight interaction between cells and mediators of the innate and adaptive immune system leads to the amplification and perpetuation of inflammation and tissue remodelling. The research carried out in the last year in the field of RA has improved the current knowledge on the pathogenesis of the disease, and is potentially useful to develop new therapeutic approaches. Thus, in this review we provide an overview on the new insights into RA pathogenesis, resulting from a literature search of the data published in the last year.

摘要

类风湿关节炎(RA)发病机制的潜在机制涉及免疫系统的不同组成部分。在具有RA遗传易感性的个体中,先天免疫系统和适应性免疫系统的细胞与介质之间的紧密相互作用会导致炎症的放大和持续以及组织重塑。去年在RA领域开展的研究增进了我们对该疾病发病机制的现有认识,并可能有助于开发新的治疗方法。因此,在本综述中,我们通过对去年发表的数据进行文献检索,概述了RA发病机制的新见解。

相似文献

1
Pathogenesis of rheumatoid arthritis: one year in review 2022.类风湿关节炎的发病机制:2022年回顾
Clin Exp Rheumatol. 2022 Mar;40(3):475-482. doi: 10.55563/clinexprheumatol/l9lyen. Epub 2022 Mar 10.
2
Pathogenesis of rheumatoid arthritis: one year in review 2024.类风湿关节炎发病机制:2024 年年度回顾。
Clin Exp Rheumatol. 2024 Sep;42(9):1707-1713. doi: 10.55563/clinexprheumatol/0307ed. Epub 2024 Sep 23.
3
One year in review 2021: pathogenesis of rheumatoid arthritis.2021 年回顾:类风湿关节炎的发病机制。
Clin Exp Rheumatol. 2021 May-Jun;39(3):445-452. doi: 10.55563/clinexprheumatol/j1l5l3. Epub 2021 May 21.
4
One year in review 2020: pathogenesis of rheumatoid arthritis.2020 年回顾:类风湿关节炎的发病机制。
Clin Exp Rheumatol. 2020 May-Jun;38(3):387-397. doi: 10.55563/clinexprheumatol/3uj1ng. Epub 2020 Apr 23.
5
Pathogenesis of rheumatoid arthritis: one year in review 2023.类风湿关节炎发病机制:2023 年回顾
Clin Exp Rheumatol. 2023 Sep;41(9):1725-1734. doi: 10.55563/clinexprheumatol/sgjk6e. Epub 2023 Jul 24.
6
One year in review 2017: pathogenesis of rheumatoid arthritis.2017年度回顾:类风湿关节炎的发病机制
Clin Exp Rheumatol. 2017 May-Jun;35(3):368-378. Epub 2017 Jun 7.
7
One year in review 2018: pathogenesis of rheumatoid arthritis.2018 年回顾:类风湿关节炎的发病机制。
Clin Exp Rheumatol. 2018 Mar-Apr;36(2):175-184. Epub 2018 Apr 18.
8
One year in review 2019: pathogenesis of rheumatoid arthritis.2019 年回顾:类风湿关节炎的发病机制。
Clin Exp Rheumatol. 2019 May-Jun;37(3):347-357. Epub 2019 May 10.
9
One year in review: the pathogenesis of rheumatoid arthritis.年度回顾:类风湿关节炎的发病机制
Clin Exp Rheumatol. 2015 Jul-Aug;33(4):551-8. Epub 2015 Jul 21.
10
The genetic pathogenesis, diagnosis and therapeutic insight of rheumatoid arthritis.类风湿关节炎的遗传发病机制、诊断和治疗见解。
Clin Genet. 2019 May;95(5):547-557. doi: 10.1111/cge.13498. Epub 2019 Jan 28.

引用本文的文献

1
The genetic puzzle of rheumatoid arthritis: Causes, progression, and treatment.类风湿关节炎的基因谜题:病因、进展与治疗
Biochem Biophys Rep. 2025 Jul 21;43:102148. doi: 10.1016/j.bbrep.2025.102148. eCollection 2025 Sep.
2
Biosimilars and reference biological medicines in the treatment of rheumatoid arthritis: a multicenter cross-sectional study in Catalonia, Spain.生物类似药与参比生物药治疗类风湿关节炎:西班牙加泰罗尼亚的一项多中心横断面研究
Clin Rheumatol. 2025 Jul 24. doi: 10.1007/s10067-025-07568-9.
3
Proteomic Profiling Reveals Novel Molecular Insights into Dysregulated Proteins in Established Cases of Rheumatoid Arthritis.
蛋白质组学分析揭示了类风湿关节炎确诊病例中失调蛋白质的新分子见解。
Proteomes. 2025 Jul 4;13(3):32. doi: 10.3390/proteomes13030032.
4
Piceatannol Inhibits the Immunostimulatory Functions of Dendritic Cells and Alleviates Experimental Arthritis.白皮杉醇抑制树突状细胞的免疫刺激功能并减轻实验性关节炎。
Int J Mol Sci. 2025 Apr 11;26(8):3626. doi: 10.3390/ijms26083626.
5
Distinctive Macrophage Migration Inhibitory Factor Receptor Patterns and Soluble Biomarkers in Rheumatoid Arthritis: Unveiling Key Associations with Disease Activity.类风湿关节炎中独特的巨噬细胞移动抑制因子受体模式和可溶性生物标志物:揭示与疾病活动的关键关联
J Interferon Cytokine Res. 2025 Mar;45(3):99-106. doi: 10.1089/jir.2024.0184. Epub 2025 Feb 6.
6
Norisoboldine Reduces Arthritis Severity by Attenuating Inflammation, Oxidative Stress, and Extracellular Matrix Degradation in a Rat Model of Rheumatoid Arthritis.去甲异波尔定通过减轻类风湿性关节炎大鼠模型中的炎症、氧化应激和细胞外基质降解来降低关节炎严重程度。
J Inflamm Res. 2024 Nov 15;17:8839-8852. doi: 10.2147/JIR.S476824. eCollection 2024.
7
Gut microbial metabolite targets HDAC3-FOXK1-interferon axis in fibroblast-like synoviocytes to ameliorate rheumatoid arthritis.肠道微生物代谢物靶向成纤维样滑膜细胞中的 HDAC3-FOXK1-干扰素轴以改善类风湿关节炎。
Bone Res. 2024 May 23;12(1):31. doi: 10.1038/s41413-024-00336-6.
8
Vigeo attenuates cartilage and bone destruction in a collagen‑induced arthritis mouse model by reducing production of pro‑inflammatory cytokines.Vigeo通过减少促炎细胞因子的产生,减轻胶原诱导的关节炎小鼠模型中的软骨和骨破坏。
Exp Ther Med. 2024 Mar 19;27(5):208. doi: 10.3892/etm.2024.12496. eCollection 2024 May.
9
Role of the 4-- signaling pathway in the pathogenesis of collagen-induced arthritis in rats.4--信号通路在大鼠胶原诱导性关节炎发病机制中的作用。 (注:原文中“4--”表述不完整,可能有信息缺失)
Heliyon. 2024 Mar 13;10(6):e27861. doi: 10.1016/j.heliyon.2024.e27861. eCollection 2024 Mar 30.
10
Augmenting regulatory T cells: new therapeutic strategy for rheumatoid arthritis.增强调节性 T 细胞:类风湿关节炎的新治疗策略。
Front Immunol. 2024 Jan 23;15:1312919. doi: 10.3389/fimmu.2024.1312919. eCollection 2024.